Skip to Main Content
Bora Acquires Pyros Pharmaceuticals to Bolster Upsher-Smith Rare Disease Product Portfolio
Upsher-Smith Laboratories, LLC
Home
Capabilities
Products
Products A-Z
Our Brands
Product Patents
Corporate Development
Corporate Development
NASPA Innovation Map
About Us
About Upsher-Smith
History
Executive Team
Awards
Charitable Activity
Policies
News
Plant C
Careers
Careers at Upsher-Smith
Company Culture
Manufacturing
Military
Students & Interns
Contact Us
Contact Upsher-Smith
Locations
800-654-2299
Capabilities
Products
Products A-Z
Our Brands
Product Patents
Corporate Development
Corporate Development
NASPA Innovation Map
About Us
About Upsher-Smith
History
Executive Team
Awards
Charitable Activity
Policies
Careers
Careers at Upsher-Smith
Company Culture
Manufacturing
Military
Students & Interns
Contact Us
Contact Upsher-Smith
Locations
Plant C
News
800-654-2299
FY2020 Financial Results for the 3rd quarter
February 12, 2021
Company News
Share:
Share on Facebook
Share on Twitter
Share on LinkedIn
Share via Email
View Press Release
Summary of Financial Results for 3Q of FY 2020
Sawai Receives Approvals for Eight Generic Drugs with 20 Strengths
Careers
Join Our Team!
We’re hiring
Search Our Jobs
Close
